PeopleBio, Inc. (KOSDAQ:304840)

Market Cap	55.25B
Revenue (ttm)	3.73B
Net Income (ttm)	-10.91B
Shares Out	21.17M
EPS (ttm)	-502.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	67,827
Average Volume	247,603
Open	2,730.00
Previous Close	2,740.00
Day's Range	2,655.00 - 2,770.00
52-Week Range	2,545.00 - 6,090.00
Beta	0.63
RSI	41.89
Earnings Date	Mar 18, 2025

About PeopleBio

PeopleBio, Inc., a biotech company, develops bioproducts for diagnostic and treatment of protein misfolding diseases. Its Multimer Detection System technology uses capturing antibodies and epitope-overlapping detection antibodies for the detection of oligomers or multimers from monomers in protein-misfolding diseases. PeopleBio, Inc. was founded in 2002 and is based in Seongnam, South Korea.

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 2002
• Employees: 66
• Stock Exchange: KOSDAQ
• Ticker Symbol: 304840

Financial Performance

In 2023, PeopleBio's revenue was 4.45 billion, an increase of 0.18% compared to the previous year's 4.44 billion. Losses were -16.03 billion, 12.1% more than in 2022.